Evidence map›Paper›PMID 23160669›Full record

ArticleIn vivo (Athens, Greece)

The zebrafish--Danio rerio--is a useful model for measuring the effects of small-molecule mitigators of late effects of ionizing irradiation.

Michael W Epperly, Nathan Bahary, Mubina Quader, Valerie Dewald, Joel S Greenberger

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Animals in Respiratory Research.International journal of molecular sciences · 2024
    Review
  3. Article
  4. Using Zebrafish as a Disease Model to Study Fibrotic Disease.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael W EpperlyDepartment of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
Nathan Bahary
Mubina Quader
Valerie Dewald
Joel S Greenberger

Funding

Training and EducationU19AI068021 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GREENBERGER, JOEL S · 2005 to 2019
$44.4M
NIAID NIH HHS U19 AI068021PHS HHS U19 A168021
6 · The paper itself

Abstract

BACKGROUND/

aimUse of zebrafish models may decrease the cost of screening new irradiation protectors and mitigators. MATERIALS AND

methodsZebrafish (Danio rerio) models were tested for screening water-soluble radiation protectors and mitigators. Irradiation of embryos and monitoring survival, and measuring fibrosis of the caudal musculature of adults allowed for testing of acute and late effects, respectively.

resultsIncubation of zebrafish embryos either before or after irradiation in ethyl pyruvate (1 mM) increased survival. Irradiation of adults to 15 to 75 Gy, delivered in single-fraction at 13 Gy/min, showed dose-dependent fibrosis at 30 days, quantitated as physiological decrease in swimming tail movement, and histopathological detection of collagen deposition in the dorsal musculature. Continuous administration of small-molecule radioprotector drugs in the water after irradiation reduced both acute and chronic injuries.

conclusionThe zebrafish is cost-effective for screening new radiation countermeasures.

Indexed as

FibrosisRadiation, IonizingRadiation-Protective AgentsAmifostineAnimalsAntioxidantsCyclic N-OxidesDose-Response Relationship, RadiationEmbryonic DevelopmentHumansOrganometallic CompoundsSalicylatesSpin LabelsSurvival AnalysisZebrafishAmifostineAntioxidantsCyclic N-OxidesEUK-134Organometallic CompoundsRadiation-Protective AgentsSalicylatesSpin Labelstempol

Identifiers

PMID23160669
PMCPMC3775014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.